Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CRDF

Cardiff Oncology (CRDF)

Cardiff Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRDF
DateTimeSourceHeadlineSymbolCompany
03/13/20254:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/13/20254:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/13/20254:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/13/20254:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/08/20257:33AMPR Newswire (Canada)Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the ChargeNASDAQ:CRDFCardiff Oncology Inc
03/08/20257:33AMPR Newswire (US)Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the ChargeNASDAQ:CRDFCardiff Oncology Inc
02/27/20254:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
02/27/20254:11PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRDFCardiff Oncology Inc
02/27/20254:05PMGlobeNewswire Inc.Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
02/27/20254:00PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRDFCardiff Oncology Inc
02/24/20254:05PMGlobeNewswire Inc.Cardiff Oncology to Present at Upcoming Investor ConferencesNASDAQ:CRDFCardiff Oncology Inc
02/20/20254:05PMGlobeNewswire Inc.Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
01/06/20254:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
12/18/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
12/17/20244:06PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CRDFCardiff Oncology Inc
12/16/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
12/10/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
12/10/20247:20AMGlobeNewswire Inc.Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct OfferingNASDAQ:CRDFCardiff Oncology Inc
12/10/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
12/10/20246:00AMGlobeNewswire Inc.Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical TrialNASDAQ:CRDFCardiff Oncology Inc
11/19/20248:00AMGlobeNewswire Inc.Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRCNASDAQ:CRDFCardiff Oncology Inc
11/07/20244:05PMGlobeNewswire Inc.Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
11/07/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
10/30/20244:30PMGlobeNewswire Inc.Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRCNASDAQ:CRDFCardiff Oncology Inc
10/24/20242:02PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CRDFCardiff Oncology Inc
08/08/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
08/08/20244:05PMGlobeNewswire Inc.Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
08/08/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
08/01/20244:05PMGlobeNewswire Inc.Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
06/17/20246:10AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRDFCardiff Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CRDF